Sackler Ruling Could Delay Purdue’s Payment of Billions by Years

OxyContin-maker Purdue Pharma could be years away from paying billions of dollars to address the U.S. opioid crisis after a judge blew up a deal that gave provided legal immunity to the Sackler family that owned the company, people close to the negotiations said. Read More